Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

929 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Terano A, Arakawa T, Sugiyama T, Suzuki H, Joh T, Yoshikawa T, Higuchi K, Haruma K, Murakami K, Kobayashi K; Rebamipide Clinical Study Group. Terano A, et al. Among authors: joh t. J Gastroenterol. 2007 Aug;42(8):690-3. doi: 10.1007/s00535-007-2076-2. Epub 2007 Aug 24. J Gastroenterol. 2007. PMID: 17701133 Clinical Trial.
Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients.
Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T. Miwa H, et al. Among authors: joh t. Helicobacter. 2004 Feb;9(1):9-16. doi: 10.1111/j.1083-4389.2004.00194.x. Helicobacter. 2004. PMID: 15156899
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Joh T, Sasaki M, Kataoka H, Tanida S, Itoh K, Kondo Y, Ogasawara N, Oshima T, Okada N, Ohara H, Sano H, Nakao H, Sobue S, Itoh M. Joh T, et al. J Gastroenterol Hepatol. 2005 Sep;20(9):1344-51. doi: 10.1111/j.1440-1746.2005.03876.x. J Gastroenterol Hepatol. 2005. PMID: 16105119
Validity of endoscopic classification of nonerosive reflux disease.
Joh T, Miwa H, Higuchi K, Shimatani T, Manabe N, Adachi K, Wada T, Sasaki M, Fujiwara Y, Hongo M, Chiba T, Kinoshita Y; ARS Research Group. Joh T, et al. J Gastroenterol. 2007 Jun;42(6):444-9. doi: 10.1007/s00535-007-2022-3. Epub 2007 Jun 29. J Gastroenterol. 2007. PMID: 17671758
It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.
Kusano M, Shirai N, Yamaguchi K, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom (ARS) Research Group. Kusano M, et al. Dig Dis Sci. 2008 Dec;53(12):3082-94. doi: 10.1007/s10620-008-0290-2. Epub 2008 May 9. Dig Dis Sci. 2008. PMID: 18465242 Clinical Trial.
929 results